Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 166
Filter
1.
Nucleic Acids Res ; 50(D1): D488-D496, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34390348

ABSTRACT

Stapled antimicrobial peptides are an emerging class of artificial cyclic peptide molecules which have antimicrobial activity and potent structure stability. We previously published the Data Repository of Antimicrobial Peptides (DRAMP) as a manually annotated and open-access database of antimicrobial peptides (AMPs). In the update of version 3.0, special emphasis was placed on the new development of stapled AMPs, and a subclass of specific AMPs was added to store information on these special chemically modified AMPs. To help design low toxicity AMPs, we also added the cytotoxicity property of AMPs, as well as the expansion of newly discovered AMP data. At present, DRAMP has been expanded and contains 22259 entries (2360 newly added), consisting of 5891 general entries, 16110 patent entries, 77 clinical entries and 181 stapled AMPs. A total of 263 entries have predicted structures, and more than 300 general entries have links to experimentally determined structures in the Protein Data Bank. The update also covers new annotations, statistics, categories, functions and download links. DRAMP is available online at http://dramp.cpu-bioinfor.org/.


Subject(s)
Anti-Infective Agents/chemistry , Antimicrobial Peptides/chemistry , Immunologic Factors/chemistry , Peptides, Cyclic/chemistry , Software , Amino Acid Sequence , Amino Acids , Animals , Anti-Infective Agents/classification , Anti-Infective Agents/pharmacology , Antimicrobial Peptides/classification , Antimicrobial Peptides/pharmacology , Bacteria/drug effects , Bacteria/growth & development , Biomimetic Materials , Databases, Protein , Erythrocytes/cytology , Erythrocytes/drug effects , Humans , Immunologic Factors/classification , Immunologic Factors/pharmacology , Internet , Mice , Molecular Sequence Annotation , Peptides, Cyclic/classification , Peptides, Cyclic/pharmacology , Protein Stability , RAW 264.7 Cells , Structure-Activity Relationship
2.
Nucleic Acids Res ; 49(D1): D1102-D1112, 2021 01 08.
Article in English | MEDLINE | ID: mdl-33125057

ABSTRACT

Peptide-drug conjugates are organic molecules composed of (i) a small drug molecule, (ii) a peptide and (iii) a linker. The drug molecule is mandatory for the biological action, however, its efficacy can be enhanced by targeted delivery, which often also reduces unwanted side effects. For site-specificity the peptide part is mainly responsible. The linker attaches chemically the drug to the peptide, but it could also be biodegradable which ensures controlled liberation of the small drug. Despite the importance of the field, there is no public comprehensive database on these species. Herein we describe ConjuPepBD, a freely available, fully annotated and manually curated database of peptide drug conjugates. ConjuPepDB contains basic information about the entries, e.g. CAS number. Furthermore, it also implies their biomedical application and the type of chemical conjugation employed. It covers more than 1600 conjugates from Ć¢ĀˆĀ¼230 publications. The web-interface is user-friendly, intuitive, and useable on several devices, e.g. phones, tablets, PCs. The webpage allows the user to search for content using numerous criteria, chemical structure and a help page is also provided. Besides giving quick insight for newcomers, ConjuPepDB is hoped to be also helpful for researchers from various related fields. The database is accessible at: https://conjupepdb.ttk.hu/.


Subject(s)
Databases, Factual , Delayed-Action Preparations/chemistry , Drugs, Investigational/chemistry , Peptides/chemistry , Prescription Drugs/chemistry , Anti-Infective Agents/chemistry , Anti-Infective Agents/classification , Anti-Infective Agents/therapeutic use , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/classification , Anti-Inflammatory Agents/therapeutic use , Antineoplastic Agents/chemistry , Antineoplastic Agents/classification , Antineoplastic Agents/therapeutic use , Delayed-Action Preparations/classification , Delayed-Action Preparations/therapeutic use , Drugs, Investigational/classification , Drugs, Investigational/therapeutic use , Humans , Internet , Neuroprotective Agents/chemistry , Neuroprotective Agents/classification , Neuroprotective Agents/therapeutic use , Peptides/therapeutic use , Prescription Drugs/classification , Prescription Drugs/therapeutic use , Software
3.
Respiration ; 100(4): 356-363, 2021.
Article in English | MEDLINE | ID: mdl-33725699

ABSTRACT

BACKGROUND: Pulmonary complications often cause morbidity and mortality in pediatric allogeneic hematopoietic stem cell transplant (HSCT) recipients. While detection of infection and initiation of appropriate antimicrobial therapy improves survival, present techniques oftentimes do not detect infections in bronchoalveolar lavage (BAL) samples because of pretreatment with antimicrobial therapies and the need for a priori knowledge of likely viral pathogens, decreasing the yield of BAL. OBJECTIVE: We evaluated whether RNA-based massively parallel sequencing (MPS) would improve detection of infections in BAL fluid in pediatric allogeneic HSCT recipients. RESULTS: Nine patients underwent 10 BAL (1 patient underwent 2 BAL) and had sufficient BAL fluid for inclusion in this study. Clinical microbiological testing identified infections in 7 patients, and MPS identified infections in 5 patients, although some of these detected organisms were not detected by clinical testing. Results were fully concordant in 5 patients, fully discordant in 3 patients, and partially discordant in 2 patients. Bacterial, viral, and fungal infections were detected via both techniques. CONCLUSION: This suggests that MPS in conjunction with routine clinical testing increases the yield of detection of infectious organisms in the BAL fluid.


Subject(s)
Anti-Infective Agents/administration & dosage , Bronchoalveolar Lavage Fluid/microbiology , Hematopoietic Stem Cell Transplantation , Pneumonia , Sequence Analysis, RNA/methods , Adolescent , Anti-Infective Agents/classification , Bacteria/genetics , Bacteria/isolation & purification , Bronchoalveolar Lavage/methods , Female , Fungi/genetics , Fungi/isolation & purification , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Humans , Male , Patient Selection , Pediatrics/methods , Pilot Projects , Pneumonia/diagnosis , Pneumonia/drug therapy , Pneumonia/microbiology , Quality Improvement , Viruses/genetics , Viruses/isolation & purification
4.
Isr Med Assoc J ; 23(11): 708-713, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34811986

ABSTRACT

BACKGROUND: The recent increase in enterococcal urinary tract infections (EUTI) and the potential morbidity and mortality associated with inappropriate antimicrobial treatment underscores the need for early risk assessment and institution of appropriate empirical antimicrobial therapy. OBJECTIVES: To identify high-risk features associated with hospitalized patients with EUTI. METHODS: Demographic, clinical, laboratory, and bacteriological data of 285 patients hospitalized with UTI during 2016 were retrieved from the computerized database of Shamir Medical Center. Patients were divided into two groups: EUTI and non-EUTI (NEUTI), according to the presence or absence of enterococcus in the urine culture. The features of the two groups were compared. RESULTS: We obtained 300 urine cultures from 285 patients. Of the total, 80 patients (26.6%) had EUTI and 220 patients (73.3%) had NEUTI. A higher prevalence of urinary multi-bacterial cultures was found in EUTI compared to NEUTI patients (P < 0.01). Higher prevalence of permanent indwelling urinary catheter and dementia were found in hospitalized patients with community-acquired EUTI and nosocomial EUTI respectively (P = 0.02, P = 0.016) compared to patients with NEUTI. CONCLUSIONS: Indwelling urinary catheter and dementia are risk factors for EUTI in patients with community and hospital acquired infection, respectively.


Subject(s)
Anti-Infective Agents/therapeutic use , Dementia , Enterococcus , Gram-Positive Bacterial Infections , Risk Assessment/methods , Urinary Catheterization , Urinary Tract Infections , Aged , Anti-Infective Agents/classification , Catheters, Indwelling/adverse effects , Catheters, Indwelling/microbiology , Coinfection/epidemiology , Coinfection/microbiology , Dementia/diagnosis , Dementia/epidemiology , Enterococcus/drug effects , Enterococcus/isolation & purification , Female , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/etiology , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/urine , Hospitalization/statistics & numerical data , Humans , Israel/epidemiology , Male , Prevalence , Risk Factors , Treatment Outcome , Urinary Catheterization/adverse effects , Urinary Catheterization/methods , Urinary Catheters/adverse effects , Urinary Catheters/microbiology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/etiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/urine
5.
Int J Mol Sci ; 22(19)2021 Sep 23.
Article in English | MEDLINE | ID: mdl-34638568

ABSTRACT

The conventional function described for platelets is maintaining vascular integrity. Nevertheless, increasing evidence reveals that platelets can additionally play a crucial role in responding against microorganisms. Activated platelets release molecules with antimicrobial activity. This ability was first demonstrated in rabbit serum after coagulation and later in rabbit platelets stimulated with thrombin. Currently, multiple discoveries have allowed the identification and characterization of PMPs (platelet microbicidal proteins) and opened the way to identify kinocidins and CHDPs (cationic host defense peptides) in human platelets. These molecules are endowed with microbicidal activity through different mechanisms that broaden the platelet participation in normal and pathologic conditions. Therefore, this review aims to integrate the currently described platelet molecules with antimicrobial properties by summarizing the pathways towards their identification, characterization, and functional evaluation that have promoted new avenues for studying platelets based on kinocidins and CHDPs secretion.


Subject(s)
Anti-Infective Agents/blood , Blood Platelets/chemistry , Blood Platelets/microbiology , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/classification , Anti-Infective Agents/immunology , Antimicrobial Cationic Peptides/immunology , Antiparasitic Agents/immunology , Antiviral Agents/immunology , Blood Platelets/immunology , Humans , Ribonucleases/immunology
6.
J Vet Pharmacol Ther ; 43(2): 179-188, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32039497

ABSTRACT

Biopharmaceutics Classification System (BCS) has gained broad acceptance in promoting the development of human drugs. To date, the applicability of existing human BCS criteria has not been evaluated in chickens. The objective of this study was to discuss the feasibility of BCS extrapolation between species and establish a preliminary chicken BCS by classifying seven veterinary commonly used drugs including metronidazole, amoxicillin, sulfamethoxazole, sulfadiazine, ciprofloxacin hydrochloride, doxycycline hydrochloride, and trimethoprim. Firstly, we finished the determination of physiological parameters affecting solubility in chickens, including body temperature, gastrointestinal pH, and the fluid volume in the gastrointestinal tract (GI), and the drug is considered highly soluble in chicken BCS when the highest dose strength is soluble in 20.40Ā ml (fed) or 6.73Ā ml (fasted) over the pH range of 1-8 at 41Ā°C. Drug solubility classification was based on dose number calculation. Metronidazol and amoxicillin were classed differently under fed and fasted conditions. Secondly, we discussed the effect of ABC transporters (MDCK vs. MDCK-chAbcb1/Abcg2) and pH (5.5 vs. 7.4) on drug permeability and classification. The drug is classified as highly permeable when its permeability is equal to or greater than metoprolol tartrate. Though ABC transporters and pH significantly affected the permeability values of drugs (pĀ <Ā .05), the permeability classification of the drugs has not been changed except for sulfamethoxazole. This work highlights some of the significant challenges that would be encountered in order to develop a chicken BCS, this valuable information could serve as a helpful tool during chicken drugs development and to minimize the potential risks when developing formulations.


Subject(s)
Anti-Infective Agents/classification , Anti-Infective Agents/pharmacokinetics , Chickens/metabolism , Animals , Anti-Infective Agents/chemistry , Biological Transport , Caco-2 Cells , Dogs , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/physiology , Humans , Hydrogen-Ion Concentration , Madin Darby Canine Kidney Cells , Permeability , Solubility
7.
Photochem Photobiol Sci ; 18(1): 12-14, 2019 Jan 01.
Article in English | MEDLINE | ID: mdl-30362478

ABSTRACT

The use of a separate nomenclature for the application of photosensitisers to the oncological and infectious disease fields represents a sensible approach. There is commonality, of course, in that both utilise light activation and act via the local generation of reactive oxygen species, but the difference in cellular targets is so great that different designs are required to achieve proper selectivity for a clinical end use, whether in human or veterinary medicine. The following represents a personal view, and perhaps a clarification of terms, in what might be considered a major etymological dichotomy existing within photodynamic research, on the 20th anniversary of "PACT".


Subject(s)
Anti-Infective Agents/classification , Anti-Infective Agents/therapeutic use , Communicable Diseases/drug therapy , Neoplasms/drug therapy , Photochemotherapy , Photosensitizing Agents/classification , Photosensitizing Agents/therapeutic use , Animals , Communicable Diseases/veterinary , Humans , Neoplasms/veterinary , Reactive Oxygen Species/metabolism
8.
Appl Microbiol Biotechnol ; 103(2): 589-602, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30456577

ABSTRACT

Biosurfactants are surface-active molecules that are synthesised non-ribosomally by a wide range of microorganisms including bacteria, yeast and filamentous fungi. The bacterial genus Serratia is gaining international interest, as biosurfactants produced by this genus have emerged as a promising source of antimicrobial, antifouling and antitumour compounds that possess emulsification and surface activity. Various species of Serratia have been identified as biosurfactant producers, including Serratia marcescens, Serratia rubidaea and Serratia surfactantfaciens. Members of the Serratia genus have been reported to principally produce two classes of biosurfactants, namely lipopeptides and glycolipids. Lipopeptides produced by Serratia species include serrawettins and stephensiolides, while identified glycolipids include rubiwettins and rhamnolipids. This review will primarily focus on the classification of biosurfactants produced by Serratia species and the genes and mechanisms involved in the biosynthesis of these biosurfactant compounds. Thereafter, an indication of the primary growth conditions and nutrient composition required for the optimum production of biosurfactants by this genus will be outlined. An overview of the latest advances and potential applications of the biosurfactants produced by Serratia in the medical, pharmaceutical, agricultural and petroleum industries is also provided.


Subject(s)
Glycolipids/chemistry , Glycolipids/metabolism , Lipopeptides/chemistry , Lipopeptides/metabolism , Serratia/metabolism , Surface-Active Agents/chemistry , Surface-Active Agents/metabolism , Anti-Infective Agents/chemistry , Anti-Infective Agents/classification , Anti-Infective Agents/metabolism , Antineoplastic Agents/chemistry , Antineoplastic Agents/classification , Antineoplastic Agents/metabolism , Glycolipids/classification , Lipopeptides/classification , Surface-Active Agents/classification
9.
Molecules ; 24(14)2019 Jul 23.
Article in English | MEDLINE | ID: mdl-31340530

ABSTRACT

Solidago species are often used in traditional medicine as anti-inflammatory, diuretic, wound-healing and antimicrobial agents. Still, the bioactive compounds and biological activities of some species have not been studied. The present work aimed to investigate the polyphenolic profile and the biological properties of Solidago graminifolia L. Salisb., a poorly explored medicinal plant. The hydroalcoholic extracts from aerial parts were evaluated for total phenolic content (TPC), total flavonoid content (TFC) and the polyphenolic compounds were investigated by HPLC-MS. The antioxidant potential in vitro was determined using DPPH and FRAP assays. Antibacterial and antifungal effects were evaluated by dilution assays and MIC, MBC and MFC were calculated. The results showed that Solidago graminifolia aerial parts contain an important amount of total phenolics (192.69 mg GAE/g) and flavonoids (151.41 mg RE/g), with chlorogenic acid and quercitrin as major constituents. The hydroalcoholic extracts showed promising antioxidant and antimicrobial potential, with potent antibacterial activity against Staphylococcus aureus and important antifungal effect against Candida albicans and C. parapsilosis. The obtained results indicated that the aerial parts of Solidago graminifolia could be used as novel resource of phytochemicals in herbal preparations with antioxidant and antimicrobial activities.


Subject(s)
Anti-Infective Agents/isolation & purification , Antioxidants/isolation & purification , Chlorogenic Acid/isolation & purification , Flavonoids/isolation & purification , Phenols/isolation & purification , Quercetin/analogs & derivatives , Solidago/chemistry , Anti-Infective Agents/classification , Anti-Infective Agents/pharmacology , Antioxidants/classification , Antioxidants/pharmacology , Biphenyl Compounds/antagonists & inhibitors , Candida albicans/drug effects , Candida albicans/growth & development , Candida parapsilosis/drug effects , Candida parapsilosis/growth & development , Chloroform/chemistry , Chlorogenic Acid/pharmacology , Ethanol/chemistry , Flavonoids/classification , Flavonoids/pharmacology , Methanol/chemistry , Microbial Sensitivity Tests , Phenols/classification , Phenols/pharmacology , Picrates/antagonists & inhibitors , Plant Components, Aerial/chemistry , Plant Extracts/chemistry , Quercetin/isolation & purification , Quercetin/pharmacology , Solvents/chemistry , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development
10.
BMC Genomics ; 19(Suppl 7): 672, 2018 Sep 24.
Article in English | MEDLINE | ID: mdl-30255784

ABSTRACT

BACKGROUND: Antimicrobial peptides are a promising alternative for combating pathogens resistant to conventional antibiotics. Computer-assisted peptide discovery strategies are necessary to automatically assess a significant amount of data by generating models that efficiently classify what an antimicrobial peptide is, before its evaluation in the wet lab. Model's performance depends on the selection of molecular descriptors for which an efficient and effective approach has recently been proposed. Unfortunately, how to adapt this method to the selection of molecular descriptors for the classification of antimicrobial peptides and the performance it can achieve, have only preliminary been explored. RESULTS: We propose an adaptation of this successful feature selection approach for the weighting of molecular descriptors and assess its performance. The evaluation is conducted on six high-quality benchmark datasets that have previously been used for the empirical evaluation of state-of-art antimicrobial prediction tools in an unbiased manner. The results indicate that our approach substantially reduces the number of required molecular descriptors, improving, at the same time, the performance of classification with respect to using all molecular descriptors. Our models also outperform state-of-art prediction tools for the classification of antimicrobial and antibacterial peptides. CONCLUSIONS: The proposed methodology is an efficient approach for the development of models to classify antimicrobial peptides. Particularly in the generation of models for discrimination against a specific antimicrobial activity, such as antibacterial. One of our future directions is aimed at using the obtained classifier to search for antimicrobial peptides in various transcriptomes.


Subject(s)
Algorithms , Anti-Infective Agents/classification , Antimicrobial Cationic Peptides/classification , Bacteria/drug effects , Evolution, Molecular , Pattern Recognition, Automated , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/pharmacology , Computer Simulation , Models, Molecular , Quantitative Structure-Activity Relationship
11.
Bioinformatics ; 33(17): 2753-2755, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28472272

ABSTRACT

SUMMARY: We have implemented the lecular esign aboratory's nti icrobial eptides package ( ), a Python-based software package for the design, classification and visual representation of peptide data. modlAMP offers functions for molecular descriptor calculation and the retrieval of amino acid sequences from public or local sequence databases, and provides instant access to precompiled datasets for machine learning. The package also contains methods for the analysis and representation of circular dichroism spectra. AVAILABILITY AND IMPLEMENTATION: The modlAMP Python package is available under the BSD license from URL http://doi.org/10.5905/ethz-1007-72 or via pip from the Python Package Index (PyPI). CONTACT: gisbert.schneider@pharma.ethz.ch. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.


Subject(s)
Anti-Infective Agents/classification , Computational Biology/methods , Machine Learning , Peptides/classification , Software , Anti-Infective Agents/chemistry , Peptides/chemistry
12.
BMC Infect Dis ; 18(1): 684, 2018 Dec 20.
Article in English | MEDLINE | ID: mdl-30572843

ABSTRACT

BACKGROUND: Meningitis remains a top cause of premature death and loss of disability-adjusted life years in low-income countries. In resource-limited settings, proper laboratory diagnostics are often scarce and knowledge about national and local epidemiology is limited. Misdiagnosis, incorrect treatment and overuse of antibiotics are potential consequences, especially for viral meningitis. METHODS: A prospective study was conducted over three months in a teaching hospital in Ethiopia with limited laboratory resources. Cerebrospinal fluid (CSF) samples from patients with suspected meningitis were analysed using a multiplex PCR-based system (FilmArray, BioFire), in addition to basic routine testing with microscopy and culture. Clinical data, as well as information on treatment and outcome were collected. RESULTS: Two hundred and eighteen patients were included; 117 (54%) neonates (0-29 days), 63 (29%) paediatrics (1 month-15 years) and 38 (17%) adults (≥16 years). Of 218 CSF samples, 21 (10%) were PCR positive; 4% in neonates, 14% in paediatrics and 18% in adults. Virus was detected in 57% of the PCR positive samples, bacteria in 33% and fungi in 10%. All CSF samples that were PCR positive for a bacterial agent had a white cell count ≥75 cells/mm3 and/or turbid appearance. The majority (90%) of patients received more than one antibiotic for treatment of the meningitis episode. There was no difference in the mean number of different antibiotics received or in the cumulative number of days with antibiotic treatment between patients with a microorganism detected in CSF and those without. CONCLUSIONS: A rapid molecular diagnostic system was successfully implemented in an Ethiopian setting without previous experience of molecular diagnostics. Viral meningitis was diagnosed for the first time in routine clinical practice in Ethiopia, and viral agents were the most commonly detected microorganisms in CSF. This study illustrates the potential of rapid diagnostic tests for reducing antibiotic usage in suspected meningitis cases. However, the cost of consumables for the molecular diagnostic system used in this study limits its use in low-income countries.


Subject(s)
Anti-Infective Agents/classification , Anti-Infective Agents/therapeutic use , Meningitis/diagnosis , Meningitis/drug therapy , Molecular Diagnostic Techniques , Multiplex Polymerase Chain Reaction , Practice Patterns, Physicians' , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Infective Agents/economics , Child , Child, Preschool , Diagnosis, Differential , Ethiopia , Female , Health Resources , Hospitals, Teaching/economics , Humans , Infant , Infant, Newborn , Male , Meningitis/cerebrospinal fluid , Meningitis/genetics , Meningitis, Bacterial/cerebrospinal fluid , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapy , Meningitis, Viral/cerebrospinal fluid , Meningitis, Viral/diagnosis , Meningitis, Viral/drug therapy , Middle Aged , Molecular Diagnostic Techniques/economics , Molecular Diagnostic Techniques/methods , Molecular Diagnostic Techniques/trends , Multiplex Polymerase Chain Reaction/economics , Practice Patterns, Physicians'/economics , Practice Patterns, Physicians'/standards , Practice Patterns, Physicians'/trends , Quality Improvement , Young Adult
13.
BMC Infect Dis ; 18(1): 590, 2018 Nov 20.
Article in English | MEDLINE | ID: mdl-30458721

ABSTRACT

BACKGROUND: Men with urinary retention secondary to benign prostatic hyperplasia (BPH) are prone to genitourinary infections. Physicians should be aware of the current antimicrobial susceptibility pattern in this population if empirical treatment is needed. The goal of this study was to evaluate variations in prevalence, composition and antimicrobial susceptibility of bacterial flora in men with indwelling catheters subjected to surgery for BPH in chosen time periods since 1994. Necessary changes in empirical therapy were also assessed. METHODS: All patients with indwelling catheters admitted to a single urological center for BPH surgery in the years 1994-1996, 2004-2006, and 2011-2015 were considered. Catheterization times and results of urine cultures from samples collected at admission were evaluated. Susceptibility for selected antimicrobials was compared separately for Gram negative and Gram positive species. For each agent and for their combinations effectiveness of empirical therapy was calculated dividing the number of patients with bacteriuria susceptible to the agents by the total number of patients with bacteriuria. RESULTS: Bacteriuria was present in 70% of 169, 72% of 132, and 69% of 156 men in the respective time periods. The incidence of Gram-positive strains increased from 10 to 37% (P < 0.001). Their susceptibility to amoxicillin/clavulanate was fluctuating (81, 61, 77%; P=NS). No vancomycin-resistant strain was present. Gram-negative flora composition was stable. Their susceptibility decreased to ciprofloxacin (70 to 53%; P = 0.01) and amoxicillin/clavulanate (56 to 37%; P < 0.01) while it increased to gentamycin (64 to 88%; P < 0.001) and co-trimoxazole (14 to 62%; P < 0.001); susceptibility to amikacin remained high (> 85%). Only two cases of resistance to carbapenems in 2004-2006 were found. In vitro effectiveness of amikacin + amoxicillin/clavulanate in empirical therapy was slowly decreasing (87 to 77%; P=NS). Imipenem was found the most effective single agent (90-95%) and its efficacy was even improved by adding vancomycin (97-98%). CONCLUSIONS: Substantial rise in the incidence of Gram-positive species and fluctuations in antimicrobial susceptibility patterns were found. Empirical therapy of genitourinary infection in catheterized men with BPH should now involve antimicrobial agents effective both to Enterococci and Enterobacteriaceae. Periodic monitoring and publishing data on antimicrobial susceptibility for this population is necessary.


Subject(s)
Anti-Infective Agents/therapeutic use , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Drug Resistance, Bacterial , Prostatic Hyperplasia/microbiology , Urinary Catheters/microbiology , Anti-Infective Agents/classification , Bacteriuria/epidemiology , Bacteriuria/microbiology , Catheter-Related Infections/complications , Catheter-Related Infections/drug therapy , Catheterization/adverse effects , Catheterization/statistics & numerical data , Drug Resistance, Bacterial/drug effects , Enterobacteriaceae/classification , Enterobacteriaceae/drug effects , Enterobacteriaceae/growth & development , Enterobacteriaceae/isolation & purification , Humans , Male , Microbial Sensitivity Tests , Prevalence , Prostatic Hyperplasia/complications , Prostatic Hyperplasia/epidemiology , Prostatic Hyperplasia/therapy , Retrospective Studies , Urinary Catheters/adverse effects , Urinary Retention/complications , Urinary Retention/epidemiology , Urinary Retention/microbiology , Urinary Retention/therapy
14.
Ann Clin Microbiol Antimicrob ; 17(1): 2, 2018 Feb 03.
Article in English | MEDLINE | ID: mdl-29397046

ABSTRACT

Infection in surgical incision often results in poor wound healing, and one of the main factors for wound infection is the use of antimicrobial agents. Rational use of antibiotics is one of the key factors to prevent incision infection in general surgery. The number of current clinical studies on antibiotic use before and during surgery is greater than that of systematic studies on antibiotic use after surgery. For the rational use of antibiotics and improvement of wound healing rate, researchers around the world have gradually focused on the use of antibiotics after surgery. Despite the familiarity on the concept of "rational use of antibiotics", few clear and systematic studies were conducted to elucidate the effect of different antibiotics on wound healing. Therefore, this review focuses on the use of different types of antimicrobial agents in surgical wounds.


Subject(s)
Anti-Infective Agents/classification , Anti-Infective Agents/therapeutic use , Surgical Wound Infection/prevention & control , Surgical Wound/prevention & control , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/classification , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/administration & dosage , Antibiotic Prophylaxis/classification , Humans , Wound Healing
15.
Acta Psychiatr Scand ; 135(2): 97-105, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27870529

ABSTRACT

OBJECTIVE: Severe infections are associated with increased risks of mental disorders; however, this is the first large-scale study investigating whether infections treated with anti-infective agents in the primary care setting increase the risks of schizophrenia and affective disorders. METHOD: We identified all individuals born in Denmark 1985-2002 (N = 1 015 447) and studied the association between infections treated with anti-infective agents and the subsequent risk of schizophrenia and affective disorders during 1995-2013. Cox regression analyses were adjusted for important confounders. RESULTS: Infections treated with anti-infective agents were associated with increased risks of schizophrenia by a hazard rate ratio (HRR) of 1.37 (95%-CI = 1.20-1.57) and affective disorders by a HRR of 1.64 (95%-CI = 1.48-1.82), fitting a dose-response and temporal relationship (P < 0.001). The excess risk was primarily driven by infections treated with antibiotics, whereas infections treated with antivirals, antimycotics, and antiparasitic agents were not significant after mutual adjustment. Individuals with infections requiring hospitalization had the highest risks for schizophrenia (HRR = 2.05; 95%-CI = 1.77-2.38) and affective disorders (HRR = 2.59; 95%-CI = 2.31-2.89). CONCLUSION: Infections treated with anti-infective agents and particularly infections requiring hospitalizations were associated with increased risks of schizophrenia and affective disorders, which may be mediated by effects of infections/inflammation on the brain, alterations of the microbiome, genetics, or other environmental factors.


Subject(s)
Anti-Infective Agents/adverse effects , Communicable Diseases/drug therapy , Mood Disorders/epidemiology , Schizophrenia/epidemiology , Adolescent , Adult , Anti-Infective Agents/classification , Communicable Diseases/complications , Denmark/epidemiology , Female , Hospitalization/statistics & numerical data , Humans , Incidence , Male , Middle Aged , Proportional Hazards Models , Registries , Risk Factors , Young Adult
16.
Antimicrob Agents Chemother ; 58(8): 4666-74, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24890584

ABSTRACT

A population-based cohort study was conducted in the Dutch PHARMO database to investigate prevalence and patterns of anti-infective medication use in children and adolescents with type 1 diabetes (T1D) before and after the onset of this disease. All patients <19 years with at least 2 insulin prescriptions (1999 to 2009) were identified (T1D cohort) and compared with an age- and sex-matched (ratio: 1 up to 4) diabetes-free reference group. The prevalence and average number of anti-infective use was studied from (up to) 8 years before until a maximum of 4 years after the onset of T1D. A total of 925 patients with T1D and 3,591 children and adolescents in the reference cohort (51% boys, mean age of 10.1 [standard deviation, 4.5] years) were included. The overall prevalence of anti-infective use (62.6 compared to 52.6%, P < 0.001) and average number of prescriptions (2.71 compared to 1.42 per child, P < 0.001) in the T1D cohort were significantly higher than those in the reference cohort after the onset of diabetes. This pattern was consistent across sex and age categories and already observed in the year before the onset of type 1 diabetes. Patients in the T1D cohort received more antibacterials (49.8 compared to 40%, P < 0.001), antimycotics (4.0 compared to 1.3%, P < 0.001), antivirals (2.5 compared to 0.4%, P < 0.001), and second-line antibiotics, such as aminoglycosides, quinolones, and third-generation cephalosporins and carbapenems. Our findings that elevated anti-infective use in the T1D cohort exists in the period before the onset of type 1 diabetes and the consumption of more second-line anti-infective compounds in this time period warrant further research.


Subject(s)
Anti-Infective Agents/therapeutic use , Communicable Diseases/drug therapy , Diabetes Mellitus, Type 1/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Adolescent , Anti-Infective Agents/classification , Case-Control Studies , Child , Cohort Studies , Communicable Diseases/complications , Diabetes Mellitus, Type 1/complications , Female , Humans , Male
17.
Mymensingh Med J ; 23(4): 709-14, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25481589

ABSTRACT

A cross-sectional descriptive study was conducted in the Neonatal Intensive Care Unit (NICU) of Ad-din Medical College Hospital during the period of January to December 2011 to determine the pattern of bacterial agents causing neonatal sepsis and their susceptibility pattern to various antimicrobial agents. Blood cultures were performed on admitted newborn babies (0-28 days) to rule out sepsis. Antimicrobial susceptibility testing was done for all blood culture isolates according to the criteria of the National Committee for Clinical Laboratory Standards by disk diffusion method. Out of 1000 screened blood cultures, 87(8.7%) reported as positive and the gram positive and gram negative bacteria accounted for 21(24.1%) and 66(75.9%) respectively. The most common gram positive organisms were Coagulase Negative Staphylococcus Aureus (CONS) (18.4%) and Staphylococcus Aureus (4.6%) and gram negative organisms were Acinetobacter (34.4%), Pseudomonas (21.8%) and Klebsiella spp. (6.9%). The susceptibilities were remarkably low to Ampicillin (20%) and Cefotaxim (29.6%) for both gram positive & gram negative isolates. Gram positive group had susceptibilities of 71.1% to Gentamicin, 85.7% to Imipenem & 100% to Amikacin & Vancomycin. Gram negative isolates showed higher sensitivities to Colistin (96.9%), Piperacillin-Tazobactum (78.7%), Imipenem (74.2%), Levofloxacillin (71.2%), respectively. Gram-negative bacteria showed high level of resistance to commonly used antibiotics (Ampicillin, Ceftazidim and Cefotaxim). Gentamicin, Amikacin, Imipenem and Levofloxacin were the most effective drugs compared to others. Routine bacterial surveillance and their sensitivity patterns must be an essential component of neonatal care.


Subject(s)
Anti-Infective Agents , Klebsiella , Pseudomonas , Sepsis , Staphylococcus aureus , Anti-Infective Agents/classification , Anti-Infective Agents/pharmacology , Bangladesh/epidemiology , Cross-Sectional Studies , Female , Humans , Infant, Newborn , Intensive Care Units, Neonatal/statistics & numerical data , Klebsiella/drug effects , Klebsiella/isolation & purification , Male , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/statistics & numerical data , Pseudomonas/drug effects , Pseudomonas/isolation & purification , Sepsis/diagnosis , Sepsis/drug therapy , Sepsis/epidemiology , Sepsis/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
18.
Mol Biol Rep ; 39(6): 6943-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22307792

ABSTRACT

Hylarana is a well established frog genus coming under the family Ranidae. An increasing number of antimicrobial peptides have been isolated and characterized from the skin of frogs of this genus. This review covers the antimicrobial peptides reported so far from the frogs of Hylarana genus and to propose a consistent system of nomenclature for amphibian skin peptides. Multiple sequence alignment of the skin peptides from Hylarana genus has grouped them into six peptide families, and three bioactive peptides. Existing nomenclature of amphibian antimicrobial peptides is species centered with no implication to the genus which can lead to disparities, when frogs with same species name belonging to different genus have to be named. As per the proposed system the peptide should have the parent peptide name (e.g. Brevinin-1) followed by two uppercase letter of the genus, if two genera begin with the same letter-first letter should be the same followed by an appropriate second letter (e.g. HU for Huia and HM for Humenerana). This is succeeded by species name in lower case-orthologous peptides from different species may be characterized by the initial letter of that species, when two species begin with the same initial letter, second letter should be used appropriately (e.g. HLat for Hylarana aurata and HLan for Hylarana aurantiaca). Paralogs belonging to the same peptide family are assigned by numbers.


Subject(s)
Amphibian Proteins/classification , Anti-Infective Agents/classification , Antimicrobial Cationic Peptides/classification , Hemolytic Agents/classification , Ranidae/metabolism , Amino Acid Sequence , Amphibian Proteins/chemistry , Amphibian Proteins/isolation & purification , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/isolation & purification , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/isolation & purification , Hemolytic Agents/chemistry , Hemolytic Agents/isolation & purification , Molecular Sequence Data , Skin/metabolism , Terminology as Topic
19.
Rev Sci Tech ; 31(1): 15-21, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22849264

ABSTRACT

Bacteria have a remarkable ability to adapt, evolve and survive by developing resistance to therapeutic compounds. This ability is also shared by other pathogenic agents such as viruses, fungi, and parasites. Even when focusing on bacterial resistance only, this phenomenon is quite complex to analyse due to the diversity of animal species, the diversity of rearing environment, the number of antimicrobial classes available and the diversity of pathogenic bacteria involved. This introductory paper includes developments on the place of antiviral compounds in veterinary medicine and a classification of antimicrobials used in food-producing animals.


Subject(s)
Anti-Infective Agents/classification , Drug Resistance, Microbial , Animals , Humans
20.
Rev Sci Tech ; 31(1): 189-97, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22849275

ABSTRACT

The aquaculture industry has grown dramatically, and plays an important role in the world's food supply chain. Antimicrobial resistance in bacteria associated with food animals receives much attention, and drug use in aquaculture is also an important issue. There are many differences between aquatic and terrestrial management systems, such as the methods used for administration of drugs. Unique problems are related to the application of drugs in aquatic environments. Residual drugs in fish products can affect people who consume them, and antimicrobials released into aquatic environments can select for resistant bacteria. Moreover, these antimicrobial-resistant bacteria, or their resistance genes, can be transferred to humans. To decrease the risks associated with the use of antimicrobials, various regulations have been developed. In addition, it is necessary to prevent bacterial diseases in aquatic animals by vaccination, to improve culture systems, and to monitor the amount of antimicrobial drugs used and the prevalence of antimicrobial-resistant bacteria.


Subject(s)
Anti-Infective Agents/administration & dosage , Aquaculture/methods , Bacterial Infections/veterinary , Fish Diseases/drug therapy , Animals , Anti-Infective Agents/classification , Aquaculture/economics , Aquaculture/standards , Bacterial Infections/drug therapy , Bacterial Infections/prevention & control , Drug Resistance, Bacterial , Fish Diseases/microbiology , Fish Diseases/prevention & control , Fish Products/microbiology , Fish Products/standards , Fishes , Vaccination/methods , Vaccination/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL